In contrast, CXCL12 exhibits a dual role in renal diseases; some studies have demonstrated that CXCL12 blockade increases podocyte numbers, reduces proteinuria, and promotes glomerular repair (Romoli et al., 2018). Here, CXCL12 is linked to kidney disorder.